A John Camm Selected Research

vanoxerine (I 893)

1/2016	Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.
6/2015	COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A John Camm Research Topics

Disease

154	Atrial Fibrillation 02/2022 - 08/2002
75	Stroke (Strokes) 01/2022 - 11/2005
35	Hemorrhage 01/2022 - 01/2008
28	Heart Failure 01/2022 - 11/2002
27	Cardiac Arrhythmias (Arrythmia) 08/2020 - 04/2002
16	Embolism (Embolus) 01/2022 - 09/2002
15	Myocardial Infarction 01/2014 - 09/2002
14	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 10/2004
10	Ventricular Tachycardia 11/2022 - 01/2003
10	Torsades de Pointes (Torsade de Pointes) 01/2016 - 11/2003
9	Heart Diseases (Heart Disease) 01/2022 - 01/2002
8	Bradycardia 01/2022 - 12/2003
8	Acute Coronary Syndrome 10/2021 - 09/2002
6	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2022 - 01/2002
6	Atrial Flutter (Flutter, Atrial) 01/2022 - 09/2002
6	Tachycardia (Tachyarrhythmias) 01/2019 - 09/2002
6	Neoplasms (Cancer) 01/2018 - 05/2013
6	Ischemic Stroke 01/2018 - 05/2013
5	Left Ventricular Dysfunction 01/2022 - 11/2002
5	Long QT Syndrome 01/2022 - 01/2002
5	Hypertension (High Blood Pressure) 02/2021 - 05/2012
5	Thromboembolism 02/2021 - 09/2002
5	Inflammation (Inflammations) 01/2020 - 09/2002
5	Chronic Renal Insufficiency 01/2019 - 05/2013
4	Brugada Syndrome 01/2010 - 05/2009
3	Diabetes Mellitus 12/2021 - 12/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2021 - 09/2002
3	Vascular Diseases (Vascular Disease) 02/2021 - 12/2019
3	Liver Diseases (Liver Disease) 01/2018 - 01/2002
3	Fibrosis (Cirrhosis) 04/2016 - 03/2011
3	Sudden Death 08/2010 - 01/2002
2	Cognitive Dysfunction 01/2022 - 12/2009
2	Peripheral Arterial Disease 06/2021 - 11/2018
2	Cardiomyopathies (Cardiomyopathy) 01/2019 - 02/2003
2	Venous Thrombosis (Deep-Vein Thrombosis) 11/2018 - 08/2011
2	Confusion (Bewilderment) 01/2018 - 01/2018
2	Atrioventricular Block 01/2017 - 03/2008
2	Ventricular Fibrillation 01/2016 - 06/2006
2	Heart Valve Diseases (Valvular Heart Disease) 05/2012 - 02/2003
2	Shock 01/2008 - 12/2003
1	Pain (Aches) 01/2022
1	Dementia (Dementias) 01/2022

Drug/Important Bio-Agent (IBA)

52	AnticoagulantsIBA 01/2022 - 09/2002
35	Vitamin K FDA Link 12/2021 - 01/2012
22	Pharmaceutical PreparationsIBA 01/2022 - 01/2003
22	RivaroxabanIBA 06/2021 - 01/2014
21	Anti-Arrhythmia AgentsIBA 10/2021 - 11/2002
12	N(4)-oleylcytosine arabinosideIBA 06/2021 - 05/2013
9	Dronedarone FDA Link 01/2022 - 10/2008
9	Amiodarone (Amiodarona)FDA LinkGeneric 01/2020 - 09/2003
9	Warfarin (Coumadin)FDA LinkGeneric 08/2018 - 01/2008
6	Factor Xa InhibitorsIBA 02/2022 - 08/2011
6	edoxabanIBA 01/2021 - 08/2011
6	vernakalantIBA 02/2014 - 03/2008
5	Dabigatran FDA Link 11/2016 - 01/2012
5	Ion Channels (Ion Channel)IBA 04/2016 - 08/2009
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2011 - 10/2008
3	Flecainide (Tambocor)FDA LinkGeneric 01/2022 - 03/2007
3	Bisoprolol (Concor)FDA LinkGeneric 12/2020 - 11/2003
3	C-Reactive ProteinIBA 01/2020 - 09/2002
3	apixabanIBA 07/2017 - 01/2014
3	Ranolazine FDA Link 10/2015 - 05/2015
3	IvabradineIBA 07/2015 - 01/2006
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2011 - 06/2006
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2011 - 07/2005
3	Ajmaline (Wolfina)FDA Link 01/2010 - 05/2009
3	azimilideIBA 08/2006 - 03/2004
2	Moxifloxacin (Avelox)FDA Link 10/2022 - 09/2014
2	dofetilide (Tikosyn)FDA Link 01/2022 - 07/2008
2	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 01/2022 - 06/2017
2	AntithrombinsIBA 02/2021 - 05/2014
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 07/2014
2	Digoxin (Digitek)FDA LinkGeneric 12/2020 - 12/2014
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2008
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2018 - 01/2017
2	amiselimodIBA 10/2018 - 01/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2017 - 07/2017
2	CalciumIBA 04/2016 - 03/2011
2	vanoxerine (I 893)IBA 01/2016 - 06/2015
2	Propafenone (Rythmol)FDA LinkGeneric 02/2014 - 03/2007
2	Fish OilsIBA 09/2011 - 06/2006
2	Angiotensin Receptor AntagonistsIBA 05/2011 - 10/2008
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2008 - 06/2006
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2008 - 03/2005
2	DiamondIBA 02/2007 - 10/2005
2	Losartan (Cozaar)FDA LinkGeneric 07/2005 - 01/2003
1	etripamilIBA 11/2022
1	DiureticsIBA 01/2022

Therapy/Procedure

70	Therapeutics 01/2022 - 01/2002
32	Electric Countershock (Cardioversion) 01/2022 - 09/2002
13	Catheter Ablation 01/2021 - 04/2002
8	Defibrillators (Defibrillator) 01/2018 - 04/2003
8	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 06/2017 - 01/2002
7	Catheters 01/2021 - 08/2002
4	Secondary Prevention 01/2022 - 01/2008
3	Radiofrequency Ablation 01/2021 - 06/2008
2	Percutaneous Coronary Intervention 11/2018 - 04/2018
2	Drug Therapy (Chemotherapy) 11/2014 - 05/2013
2	Maze Procedure 04/2003 - 08/2002